285.99
BATS BZX Real-Time Price
As of 1:25pm ET
 -3.82 / -1.32%
Today’s Change
193.00
Today|||52-Week Range
317.72
+11.10%
Year-to-Date
Will Glaxo (GSK) Beat Earnings Estimates This Season? - Analyst Blog
May 04 / Zacks.com
Will AmerisourceBergen (ABC) Beat on Earnings Yet Again? - Analyst Blog
Apr 28 / Zacks.com
Will Zillow (Z) Disappoint Earnings Estimates This Season? - Analyst Blog
May 04 / Zacks.com
Will Gilead (GILD) Miss Q1 Earnings on Weak HCV Sales? - Analyst Blog
Apr 28 / Zacks.com
Will Zoetis (ZTS) Earnings Disappoint Expectation in Q1? - Analyst Blog
May 04 / Zacks.com
A Difficult Market Juncture
Apr 28 / TheStreet.com
Will Isis Pharmaceuticals (ISIS) Disappoint in Q1 Earnings? - Analyst Blog
May 04 / Zacks.com
Will Hospira (HSP) Earnings Surprise Estimates in Q1? - Analyst Blog
Apr 27 / Zacks.com
Can Mylan (MYL) Specialty Segment Secure Earnings Beat? - Analyst Blog
May 04 / Zacks.com
Will Generics & Currency Hit Pfizer (PFE) Q1 Earnings? - Analyst Blog
Apr 27 / Zacks.com
Is Mallinckrodt (MNK) Poised to Beat on Earnings Yet Again? - Analyst Blog
May 04 / Zacks.com
Will Bristol-Myers (BMY) Earnings Streak Continue in Q1? - Analyst Blog
Apr 27 / Zacks.com
Jim Cramer -- Buy Eaton and These Others to Profit During Market's Sea Change
May 04 / TheStreet.com
Will Epizyme (EPZM) Beat Estimates This Earnings Season? - Analyst Blog
Apr 27 / Zacks.com
MRC Global Beats on Q1 Earnings & Revenues, Shares Up - Analyst Blog
May 04 / Zacks.com
Will Merck's (MRK) Q1 Earnings be Hit by Generics & Currency? - Analyst Blog
Apr 27 / Zacks.com
What's in Store for Prothena (PRTA) this Earnings Season? - Analyst Blog
May 01 / Zacks.com
AstraZeneca Falls on Q1 Earnings Decline, Reiterates View - Analyst Blog
Apr 27 / Zacks.com
What is in Store for Aegerion (AEGR) This Earnings Season? - Analyst Blog
May 01 / Zacks.com
No end in sight to wave of pharma dealmaking
Apr 26 / FT.com
Will Keryx (KERX) Disappoint This Earnings Season? - Analyst Blog
May 01 / Zacks.com
Big Pharma Comes Under Attack From a New Hedge Fund Strategy
Apr 26 / MotleyFool.com
Pacific Biosciences: What to Look for This Quarter - Analyst Blog
May 01 / Zacks.com
3 Best Stocks for Investing in Generic Drugs
Apr 25 / MotleyFool.com
Viking Global's Shareholder Letter Talks New Positions In Google, Cheniere, Biggest W...
May 01 / Benzinga
The Parade of Weak Earnings Reports Continues - Earnings Preview
Apr 24 / Zacks.com
Is it a Miss for TrovaGene (TROV) This Earnings Season? - Analyst Blog
May 01 / Zacks.com
Orexigen's Obesity Drug Contrave Faces Generic Threat - Analyst Blog
Apr 23 / Zacks.com
Teva Beats on Q1 Earnings by Wide Margin, Ups View - Analyst Blog
Apr 30 / Zacks.com
Teva Proposes to Buy Mylan, Sends Shares Up - Analyst Blog
Apr 22 / Zacks.com
Will Endocyte (ECYT) Disappoint This Earnings Season? - Analyst Blog
Apr 29 / Zacks.com
Actavis' Botox Upper Limb Spasticity Label Expanded by FDA - Analyst Blog
Apr 21 / Zacks.com
Is Exelixis (EXEL) Likely to Report Narrower Loss in Q1? - Analyst Blog
Apr 29 / Zacks.com
Teva seeks cushion against loss of patent protection
Apr 21 / FT.com
Actavis, Medicines360 Report Publication of ACCESS IUS Efficacy, Safety Study of LILE...
Apr 28 / Benzinga
Mylan dismisses takeover interest from Teva Pharmaceuticals
Apr 17 / FT.com
Will BioMarin (BMRN) Top Earnings Again on Vimzim Sales? - Analyst Blog
Apr 28 / Zacks.com
Biotech: Making sense of the science
Apr 13 / FT.com
Will Teva's (TEVA) Earnings Streak Continue in Q1? - Analyst Blog
Apr 28 / Zacks.com
Fredric Brandt, cosmetic dermatologist, 1949-2015
Apr 10 / FT.com
Will Celgene (CELG) Beat Q1 Earnings on Strong Sales? - Analyst Blog
Apr 28 / Zacks.com
Mizuho poaches 150 fixed income staff from RBS
Apr 05 / FT.com
Will Vertex (VRTX) Surprise with a Lower Loss in Q1? - Analyst Blog
Apr 28 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account